SynthesisCardiovascular research2025
Prevalence of hypertension in Africa in the last two decades: systematic review and meta-analysis.
Synthesis in Cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence, risk factors and outcomes of macrosomia in Africa: a systematic review and meta-analysis.BMJ open · 2026Pooled it
- Medication Adherence and Lifestyle Changes Among Treated Patients with Arterial Hypertension in Family Medicine in Croatia According to the EUROASPIRE V Study: A Cross-Sectional Study.Journal of clinical medicine · 2026Article
- Hypertension Prevalence and Associated Risk Factors in a South African Population.International journal of environmental research and public health · 2026Observational
- Patterns of herbal medicine utilization for hypertension during the Sudanese crisis of 2025.Scientific reports · 2026Article
- Implementation of mobile health interventions in hypertension management and outcomes: A scoping review protocol.PloS one · 2026Article
- Implications of the 2025 AHA/ACC hypertension guideline on hypertension prevalence, treatment eligibility and blood pressure control in Nigeria: a cross-sectional comparative study.BMJ public health · 2026Article
- Cardiovascular Disease in Advanced Chronic Kidney Disease in a Tertiary Institution, Johannesburg, South Africa.International journal of nephrology and renovascular disease · 2026Article
- Pathway-specific polygenic risk scores for blood pressure traits in a West African cohort.Frontiers in cardiovascular medicine · 2026Article
- Article
- Determinants, barriers, and facilitators of healthcare access for patients with hypertension in rural Ghana: applying the Andersen-Newman model of healthcare utilization.Global health action · 2025Article
- Tanzania's NCD Transition: A Comparative Analysis of Healthy Lifestyle Behaviors for Hypertension Prevention Between Rural and Urban Adults.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Despite being the most common cardiovascular risk factor, the actual burden of hypertension is poorly characterized in Africa. We meta-analysed the most extensive pooled data to determine the overall prevalence of hypertension in Africa. Following Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines, we systematically searched Google Scholar, PubMed, ScienceDirect, and Web of Science databases to retrieve prevalence studies only on hypertension among Africans published between 2002 and 2023. Furthermore, we meta-analysed the crude and age-adjusted prevalences of hypertension using a random effect model due to the expected high heterogeneity, with logit transformation of the original proportions. Seventy-eight (out of an initial 779 screened) articles with complete data were included, with a total number of hypertension cases of 71 004 and a denominator population of 286 575, mostly from community-based studies in 23 countries. The pooled crude prevalence of hypertension was 28.5/100 persons [95% confidence interval (CI): 25.3-31.8%] and a 95% prediction interval of 7.6-65.6%; the pooled prevalence increased with age and was highest among the aged ≥75 years: 51.4% (95% CI: 42.0-60.6%) and remained highest in the Southern Africa region overall (34.8%) and in the last decade (2013-23; 44.5%). The point estimate of the pooled crude prevalence was higher among urban dwellers, 32.9% (95% CI: 26.8-39.5%), than rural residents, 26.3% (95% CI: 20.4-33.3%). In a subset of 21 articles reporting age stratification consistent with the World Health Organization standard population, the pooled age-standardized prevalence was 27.2/100 persons (95% CI: 20.9-33.6%). The burden of hypertension remains high, especially in urban areas and with increasing age. Frequent screening and treatment are recommended, especially in urban areas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.